2192 ⎘
Genetically modified animals; Animal model comprising regulated expression system Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis
#302Multi-transgenic pigs for diabetes treatment
#303Recurrent gene fusions in prostate cancer
#304Compositions and methods modulating MG29 for the treatment of diabetes
#305Transgenic Animal Model of Cancer and Methods of Use
#306Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
#307F1B-TMIR plasmid vector and transgenic mouse
#308METHODS FOR PRODUCTION OF ATRIAL PROGENITORS AND THEIR DIFFERENTIATION INTO SMOOTH MUSCLE CELLS AND CARDIOMYOCYTES
#309Methods of protein production using ovomucoid regulatory regions
#310STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#311NUCLEIC ACIDS ISOLATED FROM THE INTESTINE
#312Antibodies produced in the avian oviduct
#313QUADRUPLE TRANSGENIC NON-HUMAN ANIMAL
#314Non-human animal model for frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U)
#315METHOD FOR IDENTIFYING A RENAL FIBROSIS PROCESS USE OF SNAIL- ACTIVITY-INHIBITING COMPOUNDS IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS, METHOD FOR IDENTIFYING SAID INHIBITING COMPOUNDS, SAID PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF
#316Cardiac Conduction System (CCS) Progenitor Cells and Uses Thereof
#317Micro-RNA family that modulates fibrosis and uses thereof
#318Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors
#319SHIP-deficiency to increase megakaryocyte progenitor production
#320Transgenic animals comprising gene fusions
#321Remedy for the treatment of cardio-vascular diseases or disorders
#322Non-human animal model for lung carcinoma
#323METHOD FOR TARGETED CELL ABLATION
#324Targeted and regional cellular ablation in zebrafish
#325Infertility control of genetically modified fish
#326SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY
#327MAMMARY GLAND- SPECIFIC HUMAN ERYTHEROPOIETIN EXPRESSION VECTOR, TRANSGENIC ANIMAL AND METHOD FOR PRODUCING HUMAN ERYTHROPOIETIN USING SAME
#328Regulation of expression of PI3Kβ protein in tumors
#329Methods of increasing muscle mass using follistatin-like related gene (FLRG)
#330MEANS AND METHODS FOR ISOLATING AND DETERMINING NOVEL TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS AND COMPOSITIONS COMPRISING THE SAME
#331Antibody producing non-human mammals
#332METHOD OF MONITORING RETINOPATHY
#333RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#334Transgenic chickens with an inactivated endogenous gene locus
#335IDENTIFICATION OF GROUP OF HYPERTENSION-SUSCEPTIBILITY GENES
#336Genetically modified animal for use in evaluating harmfulness of test substance
#337Enterovirus type 71 protein and method for production
#338Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#339Method for preventing and treating cardiovascular diseases with BRCA1
#340Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof
#341Antibody producing non-human mammals
#342RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#343Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#344METHODS FOR MANIPULATING STEM CELLS
#345Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use
#346Human artificial chromosome (HAC) vector and human cell medicine comprising same
#347DOUBLE-INDUCIBLE GENE ACTIVATION SYSTEM AND ITS APPLICATIONS
#348Recurrent gene fusions in prostate cancer
#349Conditional-stop dimerizable caspase transgenic animals
#350Cre-lox based gene knockdown constructs and methods of use thereof
#351CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases
#352Model animal of schizophrenia
#353ANIMAL MODELS FOR OBESITY AND NEURODEGENERATIVE DISEASES
#354Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#355SUBTRACTIVE TRANSGENICS
#356Neurotrypsin overexpressing animal
#357Targeted delivery of glycine receptors to excitable cells
#358Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
#359Methods of identifying small molecules for renewal, survival and migration of cardiac progenitors
#360Recurrent gene fusions in prostate cancer
#361Transgenically produced fusion proteins
#362Methods and compositions for using aleveolar macrophage phospholipase A2
#363Methods and compositions for using alveolar macrophage phospholipase A2
#364Genomic modification
#365Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells
#366Method for isolating cell type-specific mRNAs
#367Ovomucoid promoters and methods of use